# Minocycline Bioequivalence Study

> **NCT01938508** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 28 (actual)

## Conditions studied

- Skin Diseases

## Interventions

- **DRUG:** Minocycline

## Key facts

- **NCT ID:** NCT01938508
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2013-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01938508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01938508, "Minocycline Bioequivalence Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01938508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*